ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $74,176,000 | +35.1% | 431,009 | -1.5% | 0.19% | +35.5% |
| Q2 2021 | $54,919,000 | -9.9% | 437,633 | -2.6% | 0.14% | -19.4% |
| Q1 2021 | $60,941,000 | +3.7% | 449,383 | -2.2% | 0.18% | +10.8% |
| Q4 2020 | $58,783,000 | +14.5% | 459,453 | +0.7% | 0.16% | +3.9% |
| Q3 2020 | $51,318,000 | +90.3% | 456,037 | +61.1% | 0.15% | +67.0% |
| Q2 2020 | $26,961,000 | +1017.3% | 282,998 | +954.3% | 0.09% | +810.0% |
| Q1 2020 | $2,413,000 | +64.3% | 26,842 | -3.1% | 0.01% | +100.0% |
| Q4 2019 | $1,469,000 | +30.9% | 27,709 | -2.5% | 0.01% | +25.0% |
| Q3 2019 | $1,122,000 | -15.4% | 28,412 | -12.0% | 0.00% | -20.0% |
| Q2 2019 | $1,326,000 | -16.0% | 32,281 | -4.7% | 0.01% | -16.7% |
| Q1 2019 | $1,578,000 | -25.7% | 33,870 | -30.6% | 0.01% | -40.0% |
| Q4 2018 | $2,125,000 | – | 48,785 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,449,300 | $59,537,000,000 | 6.61% |
| Foresite Capital Management II, LLC | 188,602 | $7,748,000 | 4.36% |
| Foresite Capital Management III, LLC | 254,923 | $10,472,000 | 3.43% |
| Artal Group S.A. | 1,500,000 | $61,620,000 | 2.49% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,305,174 | $53,617,000 | 1.93% |
| Asymmetry Capital Management, L.P. | 82,473 | $3,388,000 | 1.84% |
| QVT Financial LP | 190,977 | $7,845,000 | 1.66% |
| SECTORAL ASSET MANAGEMENT INC | 269,396 | $11,067,000 | 1.32% |
| Sofinnova Investments, Inc. | 241,043 | $9,902,000 | 0.91% |
| Novo Holdings A/S | 119,708 | $4,918,000 | 0.69% |